Title of article
Comparison of Stimdate with Ritalin in Children and Adolescents with Attention Deficit Hyperactivity Disorder: a Double-Blind, Randomized Clinical Trial
Author/Authors
Khosrovan Mehr، Najmeh نويسنده Alzahra University, Psychology Faculty, Tehran, Iran. Child and Adolescent Psychiatry and Rehabilitation Center, Tehran, Iran Khosrovan Mehr, Najmeh , Akhondzadeh، Shahin نويسنده , , Mohammadi، Mohammad Reza نويسنده Department of Physics, Sistan and Baluchestan University, Zahedan 98135–674, I.R. Iran , , Mohammadi، Mohammad نويسنده , , Mahintorabi، Somayeh نويسنده Child and Adolescent Psychiatry and Rehabilitation Center, Tehran, Iran Mahintorabi, Somayeh
Issue Information
فصلنامه با شماره پیاپی 0 سال 2009
Pages
5
From page
31
To page
35
Abstract
Objectives: The aim of this randomized clinical trial was to assess the efficacy of stimdate compared to ritalin in the treatment of children with attention deficit hyperactivity disorder (ADHD).
Method: Sixty four subjects (45 boys and 15 girls) aged 5-13 who were diagnosed with ADHD based on (DSM-IV-TR) criteria were selected for this study. The subjects were randomly assigned to two groups: one group with 30 subjects received stimdate and the other group of 30 subjects received ritalin for 6 weeks. Treatment outcomes were assessed using the Attention Deficit Hyperactivity Rating Scale administered at baseline and on weeks 2, 4 and 6 following the treatment. A two-way repeated measures analysis of variance (time- treatment interaction) was used.
Results: There were no significant differences between sex, age, weight, and ethnicity of the participants in the 2 groups. Both groups showed a significant improvement during the 6 weeks of the treatment period, and this improvement was due to the parentsʹ ADHD Rating Scale during the treatment.
Conclusion: Based on the results of this study, no significant difference was observed between the two medications, and it seems both drugs behave[M1] in a similar way. In addition, stimdate appears to be effective and well tolerated for ADHD in children and adolescents in Iran.
Method: Sixty four subjects (45 boys and 15 girls) aged 5-13 who were diagnosed with ADHD based on (DSM-IV-TR) criteria were selected for this study. The subjects were randomly assigned to two groups: one group with 30 subjects received stimdate and the other group of 30 subjects received ritalin for 6 weeks. Treatment outcomes were assessed using the Attention Deficit Hyperactivity Rating Scale administered at baseline and on weeks 2, 4 and 6 following the treatment. A two-way repeated measures analysis of variance (time- treatment interaction) was used.
Results: There were no significant differences between sex, age, weight, and ethnicity of the participants in the 2 groups. Both groups showed a significant improvement during the 6 weeks of the treatment period, and this improvement was due to the parentsʹ ADHD Rating Scale during the treatment.
Conclusion: Based on the results of this study, no significant difference was observed between the two medications, and it seems both drugs behave[M1] in a similar way. In addition, stimdate appears to be effective and well tolerated for ADHD in children and adolescents in Iran.
Journal title
Iranian Journal of Psychiatry
Serial Year
2009
Journal title
Iranian Journal of Psychiatry
Record number
2392456
Link To Document